Skip to content
healthcare.dev

JOBEVNE

NDC 83257-010, bevacizumab-nwgd, injection, from Biocon Biologics Inc..

Product NDC
83257-010
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
INJECTION
Route
INTRAVASCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761175
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-010 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEVACIZUMAB25 mg/mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
83257-010-11832570010111 VIAL, SINGLE-DOSE in 1 CARTON (83257-010-11) / 16 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70ab1de6-fb68-aee4-a6cb-f9a0f146687f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83257-010

Use it

Look up 83257-010 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-010 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.